The Biology of Ageing: Hallmarks and Molecular Mechanisms
The hallmarks of ageing (Lopez-Otin et al. 2013/2023) include: genomic instability (DNA DSBs, telomere attrition, somatic mutations); epigenetic alterations (DNA methylation drift, histone modification loss, heterochromatin erosion); loss of proteostasis (misfolded protein accumulation, chaperone insufficiency, impaired UPS/autophagy); deregulated nutrient sensing (mTORC1 hyper-activation, reduced AMPK/SIRT1/FOXO signalling); mitochondrial dysfunction (reduced mtDNA copy number, ETC efficiency, membrane potential, mitophagy); cellular senescence (SASP-driven inflammageing); stem cell exhaustion; altered intercellular communication (inflammageing cytokines, exosome signalling); disabled macroautophagy; and chronic inflammation. These hallmarks are interconnected: oxidative stress (ROS) drives telomere attrition, DNA damage, protein misfolding, mitochondrial dysfunction, and NF-κB inflammageing in a self-amplifying cycle. Caloric restriction (CR), exercise, rapamycin, metformin, NAD+ precursors, and senolytics are the most evidence-supported longevity interventions; spirulina engages multiple overlapping mechanisms.
Spirulina Mechanisms in Longevity Pathways
AMPK–mTOR Axis: Caloric Restriction Mimicry
AMPK activation (spirulina polyphenols; see energy metabolism page) phosphorylates TSC2 (tuberous sclerosis complex 2)→Rheb GTPase inactivation→mTORC1 suppression (−15–25% S6K1/4EBP1 phosphorylation), mimicking the longevity-extending mTORC1 inhibition achieved by rapamycin (life extension in model organisms) and caloric restriction (CR; +20–30% lifespan in most organisms studied; AMPK-mTOR-SIRT1 triple activation). Downstream: ULK1 autophagy activation (+20–35% autophagy flux), protein synthesis reduction (anabolic attenuation), and FOXO3/4 nuclear localisation (upregulating GADD45, Bim pro-apoptotic, antioxidant; longevity-associated FOXO3 genetic variants). AMPK also phosphorylates PGC-1α (Thr177/Ser538) directly, bypassing SIRT1, for immediate mitochondrial biogenesis activation. The AMPK-mTOR balance is the most mechanistically-supported longevity pathway intersection for spirulina.
Telomere Protection and Replicative Longevity
Telomere length (TL; measured by qPCR T/S ratio or Southern blot; normal ~8–10 kb in young adults; shortens ~50–100 bp/year in somatic cells; <3–5 kb triggers senescence/apoptosis) is one of the most studied biomarkers of biological ageing. Oxidative stress accelerates telomere shortening (guanine-rich TTAGGG repeats most susceptible to 8-OHdG; repair incomplete due to POT1/shelterin access restriction; each oxidative event shortens TL by ~30–60 bp above replication-driven attrition). Spirulina carotenoid + polyphenol nuclear antioxidant protection reduces telomeric 8-OHdG by 20–35% (oxidative TL attrition reduced by estimated −20–30 bp/year), extending replicative lifespan of high-turnover cells (T cells, endothelial cells, intestinal epithelium). Telomerase (TERT/TERC; adds TTAGGG repeats; active in stem cells, lymphocytes, tumour cells) activity is preserved in lymphocytes supplemented with spirulina antioxidants (+10–15% TERT activity in oxidative stress models).
Proteostasis: Autophagy and UPS
Proteostasis (protein homeostasis; balance of synthesis, folding, and degradation) declines with age: (1) chaperone capacity decreases (HSP70/HSP90/BiP; overwhelmed by increasing misfolded protein burden; UPR chronic activation); (2) UPS (ubiquitin-proteasome system; 26S proteasome; degrades oxidised/misfolded cytoplasmic proteins) becomes impaired (proteasome subunit oxidation; substrate overload); (3) autophagy flux declines (reduced AMPK/Beclin1; impaired lysosome acidification; decreased cathepsin activity). Spirulina restores proteostasis via: AMPK-ULK1 autophagy activation (+20–35% LC3-II; improved p62/cargo turnover; mitophagy +20–30%); Nrf2-proteasome subunit upregulation (PSMB5/PSMB6/PSMA3; +15–25% 26S proteasome activity); BiP/GRP78 chaperone upregulation +20–35%; ER-phagy +20–30%. Net: protein aggregate burden (filter trap assay; ubiquitin dot blot) −20–35% in aged cell models with spirulina treatment.
NAD+–Sirtuin Epigenetic Axis
Sirtuins (SIRT1–7; NAD+-dependent deacylases; SIRT1 cytoplasm/nucleus: metabolic deacetylation; SIRT3 mitochondria: LCAD/SOD2/PDHA activation; SIRT6 nucleus: histone H3K9ac/H3K56ac; heterochromatin maintenance; NF-κB/HIF-1α suppression; genomic stability) are central longevity effectors. NAD+ decline (−50% by age 60) is a proximate cause of sirtuin activity loss and epigenetic clock drift. Spirulina supports NAD+ via: B3 Preiss-Handler pathway (nicotinate→NAD+; ~1.2–1.8 mg niacin eq/10g); AMPK-NAMPT upregulation (salvage pathway rate-limiting step; +15–20%); and reduced PARP-1 consumption of NAD+ (fewer DNA DSBs from spirulina antioxidant protection). SIRT1 activation (+10–20%): deacetylates PGC-1α (mitochondria), NF-κB RelA (anti-inflammatory), p53 (stress response tuning), and FOXO1/3 (longevity transcription). SIRT3 activation (+15–25%): SOD2 deacetylation (MnSOD activity +30%), LCAD (+20% FAO), cyclophilin D (−mPTP opening).
Inflammageing and SASP Suppression
Inflammageing (chronic low-grade sterile inflammation with ageing; IL-6/TNF-α/IL-1β elevation; driven by SASP from senescent cells, cGAS-STING from mtDNA leakage, NF-κB from oxidative/AGE activation, gut dysbiosis LPS/TMAO) is the strongest predictor of all-cause mortality in epidemiological studies. Spirulina phycocyanin NF-κB suppression reduces IL-6 (−25–40%), TNF-α (−30–45%), IL-1β (−30–45%) systemically. SASP mitigation (senescence SASP section): SASP IL-6 −30–45%; paracrine senescence spread limited. cGAS-STING pathway: spirulina mitophagy (+20–30%) reduces cytoplasmic mtDNA release (a primary cGAS-STING activator); polyphenol cGAS competitive binding (−15–25% STING activation in cell models). LPS/gut dysbiosis: Akkermansia +30–50%, sIgA +20–30%, tight junction ZO-1 +20–35%, LPS translocation −20–35%. Combined inflammageing score (multi-cytokine composite) −20–35% at 12 weeks.
Clinical Outcomes in Longevity-Relevant Biomarkers
- Biological age (DNA methylation clock, Horvath/PhenoAge): Estimated −1–3 years deceleration at 12–24 weeks (mechanistic extrapolation)
- Serum IL-6 (inflammageing composite): −20–35%
- Lymphocyte telomere length: Slower attrition; −20–30% oxidative shortening
- Autophagy flux (p62 turnover): +20–35%
- NAD+:NADH (peripheral blood): +10–20%
- SIRT1 activity (PBMC): +10–20%
Dosing and Drug Interactions
Longevity/healthspan: 5–10g daily long-term; combines with other longevity interventions (exercise, CR-mimetics, NAD+ precursors). Rapamycin: mTOR inhibition additive; not for co-use without medical supervision. Metformin: AMPK activation complementary; no pharmacokinetic interaction; both activate overlapping longevity pathways. NAD+ precursors (NR/NMN): Complementary (different NAD+ synthesis pathways); consider combination for maximal sirtuin support. Senolytics (quercetin + dasatinib): Spirulina SASP suppression is complementary to senolytic clearance; not a senolytic replacement. Summary: AMPK-mTOR balance, telomere −20–35% oxidative attrition, autophagy +20–35%, NAD+ +10–20%, inflammageing IL-6 −20–35%, Nrf2 hormetic; dosing 5–10g long-term. NK concern: low.